Smith & Nephew/SN

1.08%
-
1D1W1MYTD1YMAX

About Smith & Nephew

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.

Ticker

SN

Sector

Healthcare

Trading on

LSE

Industry

Medical Equipment & Supplies

CEO

Deepak Nath

Employees

18,452

Headquarters

Watford, United Kingdom

Smith & Nephew Metrics

BasicAdvanced
£10.63B
Market cap
40.37
P/E ratio
£0.30
EPS
0.83
Beta
£0.38
Dividend rate
3.07%
Dividend yield
£10.63B
0.83
£16.39
£11.04
3.65M
£0.38
1.775
0.72
44.451
59.114
124.33%
69.87
4.84%
2.64%
5.02%
3.29%
40.37
1.916
2.032
9.536
1.98%
3.14%
3.07%
7.97%
22.74%
6.76%
-16.14%
-15.18%

What the Analysts think about Smith & Nephew

Analyst Ratings

Majority rating from 18 analysts.
Buy

Price Targets

Average projection from 16 analysts.
30.76% upside
High £15.00
Low £10.75
£9.85
Current price
£12.88
Average price target

Smith & Nephew Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
3.23% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$2.82B
2.96%
Net income
$91M
-47.09%
Profit margin
3.23%
-48.65%

Smith & Nephew Earnings Performance

No data availble
Quarterly data is not available. You can look at the annual data instead.

Earnings per share (EPS)

Company profitability
-
QuarterlyAnnual
Actual
Expected
Surprise
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and LSEG. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Smith & Nephew stock?

Smith & Nephew (SN) has a market cap of £10.63B as of April 24, 2024.

What is the P/E ratio for Smith & Nephew stock?

The price to earnings (P/E) ratio for Smith & Nephew (SN) stock is 40.37 as of April 24, 2024.

Does Smith & Nephew stock pay dividends?

Yes, the Smith & Nephew (SN) stock pays dividends to shareholders. As of April 24, 2024, the dividend rate is £0.38205 and the yield is 3.07%. Smith & Nephew has a payout ratio of 124.33% on a trailing twelve-month basis.

When is the next Smith & Nephew dividend payment date?

The next Smith & Nephew (SN) dividend payment is scheduled for May 22, 2024.

What is the beta indicator for Smith & Nephew?

Smith & Nephew (SN) has a beta rating of 0.83. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Smith & Nephew stock price target?

The target price for Smith & Nephew (SN) stock is £12.88, which is 30.76% above the current price of £9.85. This is an average based on projections from 16 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Smith & Nephew stock

Buy or sell Smith & Nephew stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing